Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3010% above fair value
$101.25−0.35 (-0.34%)
Close on Nov 12, 2026Market cap $6.61BP/E 25.0Yield –
Lantheus gross margin
Gross margin is gross profit as a percentage of revenue.
Lantheus's gross margin for the twelve months ending Sep 30, 2026 was 61.3%. For fiscal 2025 it was 61.1%, against 64.4% the year before. The highest annual figure on record is 64.4% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61.1% | −3.3 |
| FY2024 | Dec 31, 2024 | 64.4% | +9.7 |
| FY2023 | Dec 31, 2023 | 54.7% | −7.5 |
| FY2022 | Dec 31, 2022 | 62.2% | +18.1 |
| FY2021 | Dec 31, 2021 | 44.1% | +3.3 |
| FY2020 | Dec 31, 2020 | 40.9% | −9.4 |
| FY2019 | Dec 31, 2019 | 50.3% | −0.6 |
| FY2018 | Dec 31, 2018 | 50.9% | +2.0 |
| FY2017 | Dec 31, 2017 | 48.9% | +3.3 |
| FY2016 | Dec 31, 2016 | 45.6% | −0.5 |
| FY2015 | Dec 31, 2015 | 46.2% | +4.6 |
| FY2014 | Dec 31, 2014 | 41.6% | +14.3 |
| FY2013 | Dec 31, 2013 | 27.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 62.4% | +4.5 |
| Q2 FY2026 | Jun 30, 2026 | 62.3% | −1.4 |
| Q1 FY2026 | Mar 31, 2026 | 61.2% | −2.6 |
| Q4 FY2025 | Dec 31, 2025 | 59.2% | −4.3 |
| Q3 FY2025 | Sep 30, 2025 | 57.9% | −6.0 |
| Q2 FY2025 | Jun 30, 2025 | 63.8% | −1.2 |
| Q1 FY2025 | Mar 31, 2025 | 63.8% | −1.6 |
| Q4 FY2024 | Dec 31, 2024 | 63.5% | −1.4 |
| Q3 FY2024 | Sep 30, 2024 | 63.9% | +1.4 |
| Q2 FY2024 | Jun 30, 2024 | 64.9% | +1.9 |
| Q1 FY2024 | Mar 31, 2024 | 65.4% | +39.7 |
| Q4 FY2023 | Dec 31, 2023 | 64.9% | +1.4 |
| Q3 FY2023 | Sep 30, 2023 | 62.5% | +0.9 |
| Q2 FY2023 | Jun 30, 2023 | 63.0% | +1.3 |
| Q1 FY2023 | Mar 31, 2023 | 25.6% | −36.2 |
| Q4 FY2022 | Dec 31, 2022 | 63.5% | +18.8 |
| Q3 FY2022 | Sep 30, 2022 | 61.6% | +19.8 |
| Q2 FY2022 | Jun 30, 2022 | 61.7% | +16.1 |
| Q1 FY2022 | Mar 31, 2022 | 61.8% | +17.4 |
| Q4 FY2021 | Dec 31, 2021 | 44.7% | +3.6 |
| Q3 FY2021 | Sep 30, 2021 | 41.8% | +0.9 |
| Q2 FY2021 | Jun 30, 2021 | 45.6% | +6.4 |
| Q1 FY2021 | Mar 31, 2021 | 44.4% | +2.5 |
| Q4 FY2020 | Dec 31, 2020 | 41.1% | −8.8 |
| Q3 FY2020 | Sep 30, 2020 | 41.0% | −7.5 |
| Q2 FY2020 | Jun 30, 2020 | 39.2% | −12.8 |
| Q1 FY2020 | Mar 31, 2020 | 41.9% | −9.1 |
| Q4 FY2019 | Dec 31, 2019 | 49.9% | −0.9 |
| Q3 FY2019 | Sep 30, 2019 | 48.5% | −2.0 |
| Q2 FY2019 | Jun 30, 2019 | 52.0% | +0.8 |
| Q1 FY2019 | Mar 31, 2019 | 51.0% | −0.2 |
| Q4 FY2018 | Dec 31, 2018 | 50.8% | +4.2 |
| Q3 FY2018 | Sep 30, 2018 | 50.5% | +2.3 |
| Q2 FY2018 | Jun 30, 2018 | 51.2% | −0.5 |
| Q1 FY2018 | Mar 31, 2018 | 51.2% | +2.3 |
| Q4 FY2017 | Dec 31, 2017 | 46.7% | +0.1 |
| Q3 FY2017 | Sep 30, 2017 | 48.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 51.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 48.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 46.6% | – |
See a number that looks wrong?